These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Enhanced capture system for mesenchymal‑type circulating tumor cells using a polymeric microfluidic device 'CTC‑Chip' incorporating cell‑surface vimentin. Kanayama M; Yoneda K; Kuwata T; Mori M; Manabe T; Oyama R; Matsumiya H; Takenaka M; Kuroda K; Ohnaga T; Tanaka F Oncol Rep; 2024 Nov; 52(5):. PubMed ID: 39364763 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer. Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581 [TBL] [Abstract][Full Text] [Related]
8. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs). Hyun KA; Lee TY; Lee SH; Jung HI Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749 [TBL] [Abstract][Full Text] [Related]
9. Rapid prototyping of Nanoroughened polydimethylsiloxane surfaces for the enhancement of immunomagnetic isolation and recovery of rare tumor cells. Zhang L; Li Q; Yang R; Xu Z; Kang Y; Xue P Biomed Microdevices; 2019 Jun; 21(3):58. PubMed ID: 31227909 [TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients. Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504 [TBL] [Abstract][Full Text] [Related]
11. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence. Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991 [TBL] [Abstract][Full Text] [Related]
12. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device. Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699 [TBL] [Abstract][Full Text] [Related]
13. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads. Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030 [TBL] [Abstract][Full Text] [Related]
14. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648 [TBL] [Abstract][Full Text] [Related]
15. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy. Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335 [TBL] [Abstract][Full Text] [Related]
16. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126 [TBL] [Abstract][Full Text] [Related]
17. Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ Myung JH; Cha A; Tam KA; Poellmann M; Borgeat A; Sharifi R; Molokie RE; Votta-Velis G; Hong S Anal Chem; 2019 Jul; 91(13):8374-8382. PubMed ID: 31247718 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer. Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569 [TBL] [Abstract][Full Text] [Related]
19. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [TBL] [Abstract][Full Text] [Related]
20. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter. Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]